Anchorage-Dependent Transcription of the Cyclin A Gene

REFERENCES

• Amigorena, S., C. Bonnerot, J. R. Drake, D. Choquet, W. Hunziker, J. G. Guillet, P. Webster, C. Sautes, I. Mellman, and W. H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808–1812.
   PubMed Web of Science ®Google Scholar
• Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812–821.
   PubMed Web of Science ®Google Scholar
• Bates, S., and G. Peters. 1995. Cyclin D1 as a cellular proto-oncogene. Semin. Cancer Biol. 6:73–82.
   PubMedGoogle Scholar
• Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G(1) cyclin complexes. Genes Dev. 9:1340–1353.
   PubMedGoogle Scholar
• Bohmer, R. M., E. Scharf, and R. K. Assoian. 1996. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell 7:101–111.
   PubMedGoogle Scholar
• Burridge, K., and K. Fath. 1989. Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. Bioessays 10:104–108.
   PubMed Web of Science ®Google Scholar
• Cardoso, M. C., H. Leonhardt, and B. Nadalginard. 1993. Reversal of terminal differentiation and control of DNA replication—cyclin-A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979–992.
   PubMedGoogle Scholar
• Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233–239.
   PubMed Web of Science ®Google Scholar
• D’Urso, G., R. L. Marraccino, D. R. Marshak, and J. M. Roberts. 1990. Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science 250:786–791.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., T. Kowalik, and J. R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224.
   PubMed Web of Science ®Google Scholar
• Dulic, V., L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein. 1993. Altered regulation of G(1)-cyclins in senescent human diploid fibroblasts—accumu-lation of inactive cyclin-E-Cdk2 and cyclin-D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA 90:11034–11038.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013–1023.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271:499–502.
   PubMed Web of Science ®Google Scholar
• Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169–1179.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Gramlich, T. L., C. R. Fritsch, D. Maurer, M. Eberle, and T. S. Gansler. 1994. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn. Mol. Pathol. 3:255–259.
   PubMedGoogle Scholar
• Guadagno, T., M. Ohtsubo, J. M. Roberts, and R. Assoian. 1993. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572–1575.
   PubMed Web of Science ®Google Scholar
• Guadagno, T. M., and R. K. Assoian. 1991. G1/S control of anchorage-independent growth in the fibroblast cell cycle. J. Cell Biol. 115:1419–1425.
   PubMed Web of Science ®Google Scholar
• Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581–1588.
   PubMed Web of Science ®Google Scholar
• Han, E. K., T. M. Guadagno, S. L. Dalton, and R. K. Assoian. 1993. A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-beta 1 control G1/S transit specifically. J. Cell Biol. 122:461–471.
   PubMedGoogle Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Henglein, B., X. Chenivesse, J. Wang, D. Eick, and C. Bréchot. 1994. Structure and cell cycle regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91:5490–5494.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291–5295.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177–185.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709–713.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. Pines. 1994. Cyclins and cancer. 2. Cyclin D and CDK inhibitors come of age. Cell 79:573–582.
   PubMed Web of Science ®Google Scholar
• Jansen-Dürr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Weßbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:2547–2552.
   PubMedGoogle Scholar
• Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27(Kip1)) of cyclin-dependent kinase 4 activation. Cell 79:487–496.
   PubMed Web of Science ®Google Scholar
• Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the cdc2 gene family. Cell 66:1217–1228.
   PubMed Web of Science ®Google Scholar
• Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161–172.
   PubMed Web of Science ®Google Scholar
• La Thangue, N. B. 1994. Drtf1/E2F—an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108–114.
   PubMed Web of Science ®Google Scholar
• Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874–1885.
   PubMed Web of Science ®Google Scholar
• Matsuhisa, T., and Y. Mori. 1981. An anchorage-dependent locus in the cell cycle for the growth of 3T3 cells. Exp. Cell Res. 135:393–398.
   PubMedGoogle Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., B. Sarcevic, and R. L. Sutherland. 1996. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. J. Cell. Biochem. 60:363–378.
   PubMedGoogle Scholar
• Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27(Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (London) 372:570–573.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612–2624.
   PubMed Web of Science ®Google Scholar
• Otsuka, H., and M. Moskowitz. 1975. Arrest of 3T3 cells in G1 phase in suspension culture. J. Cell Physiol. 87:213–219.
   PubMed Web of Science ®Google Scholar
• Pagano, M., G. Draetta, and P. Jansen-Dürr. 1992. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255:1144–1147.
   PubMedGoogle Scholar
• Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961–971.
   PubMed Web of Science ®Google Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Delsal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Pines, J. 1993. Cyclins and cyclin-dependent kinases—take your partners. Trends Biochem. Sci. 18:195–197.
   PubMed Web of Science ®Google Scholar
• Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associ-ated protein p60 and behaves differently from cyclin B. Nature (London) 346:760–763.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27KIP1, a cyclin-Cdk inhibitor, links transformation growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Y. Kato, D. Barsagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G(1) phase in rodent fibroblasts. Genes Dev. 7:1559–1571.
   PubMed Web of Science ®Google Scholar
• Rao, S., C. Chu, and S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259–5267.
   PubMedGoogle Scholar
• Resnitzky, D., M. Gossen, H. Bujard, and S. I. Reed. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669–1679.
   PubMed Web of Science ®Google Scholar
• Rudolph, B., R. Saffrich, J. Zwicker, B. Henglein, R. Müller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:3065–3076.
   PubMed Web of Science ®Google Scholar
• Schulze, A., K. Zerfaß, D. Spitkovsky, J. Berges, S. Middendorp, P. Jansen-Dürr, and B. Henglein. 1995. Cell cycle regulation of cyclin A gene transcription is mediated by a variant E2F binding site. Proc. Natl. Acad. Sci. USA 92:11264–11268.
   PubMedGoogle Scholar
• Schulze, A., K. Zerfass, D. Spitkovsky, B. Henglein, and P. Jansen-Dürr. 1994. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Onco-gene 9:3475–3482.
   Google Scholar
• Sherr, C. J. 1993. Mammalian G(1)-cyclins. Cell 73:1059–1065.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G(1) cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Shin, S. I., V. H. Freedman, R. Risser, and R. Pollack. 1975. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. USA 72:4435–4439.
   PubMed Web of Science ®Google Scholar
• Shiyanov, P., S. Bagchi, G. Adami, J. Kokontis, N. Hay, M. Arroyo, A. Morozov, and P. Raychaudhuri. 1996. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16:737–744.
   PubMedGoogle Scholar
• Suzuki-Takahashi, I., M. Kitagawa, M. Saijo, H. Higashi, H. Ogino, H. Matsumoto, Y. Taya, S. Nishimura, and A. Okuyama. 1995. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691–1698.
   PubMedGoogle Scholar
• Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74.
   PubMed Web of Science ®Google Scholar
• Wang, J., X. Chenivesse, B. Henglein, and C. Bréchot. 1990. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (London) 343:555–557.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Won, K. A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910–99104.
   PubMed Web of Science ®Google Scholar
• Zamanian, M., and N. B. LaThangue. 1993. Transcriptional repression by the Rb-related protein-p107. Mol. Biol. Cell 4:389–396.
   PubMed Web of Science ®Google Scholar
• Zerfass, K., A. Schulze, D. Spitkovsky, V. Friedman, B. Henglein, and P. Jansen-Dürr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:6389–6399.
   PubMedGoogle Scholar
• Zerfass-Thome, K. Unpublished data.
   Google Scholar
• Zerfass-Thome, K., et al. Unpublished data.
   Google Scholar
• Zhou, P., W. Jiang, Y. J. Zhang, S. M. Kahn, I. Schieren, R. M. Santella, and I. B. Weinstein. 1995. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11:571–580.
   PubMed Web of Science ®Google Scholar
• Zhu, L., E. Harlow, and B. D. Dynlacht. 1995. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interaction with E2F. Genes Dev. 9:1740–1752.
   PubMed Web of Science ®Google Scholar
• Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, D. Fesquet, J. Wang, B. Henglein, and C. Bréchot. 1991. Cyclin A is required in S phase in normal epithelial cells. Biophys. Biochem. Res. Commun. 182:1144–1154.
   Google Scholar